Sign up to our LEAP Local quarterly newsletter

Dr Kasozi secured resources for the National Drug Resistant TB survey, helped finalize protocols and train staff, and advocated for lab accreditation. The TA also supported improvements in TB/ HIV collaboration, medicine stock management, and lab systems. Through participation in meetings and piloting a patient tracker, the TA fostered collaboration and better case management. The TA additionally contributed to expanding access to treatment by supporting the establishment of DR-TB decentralization sites. This initiative aimed to improve patient outcomes by bringing care closer to where people live.

–

The TA supported the establishment of DR-TB decentralization sites to optimize treatment outcomes. This aimed to address the challenge of over-decentralization and lack of capacity at various sites.